With the world facing acute shortage in Covid-19 vaccines, WHO’s nod for global use of China’s Sinopharm vaccine provides a huge relief.
IN recent weeks, there has been an incessant flow of exciting news on Chinese vaccines that carries wide-ranging implications for China as well as vaccine-deprived developing countries.
On May 7, the World Health Organisation announced its approval for emergency use a Covid-19 vaccine from China’s government-owned drugmaker Sinopharm, greenlighting it to be rolled out globally.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!